title: Neutrophil count in African Americans: lowering the target cutoff to initiate or resume chemotherapy?
authors.affiliation: Molecular and Clinical Hematology Branch, National Institute of Diabetes, Digestive, and Kidney Diseases, National Heart, Lung, and Blood Institute, Bethesda, MD, USA.
authors.forename: Matthew M
authors.initials: MM
authors.lastname: Hsieh
authors.forename: John F
authors.initials: JF
authors.lastname: Tisdale
authors.forename: Griffin P
authors.initials: GP
authors.lastname: Rodgers
authors.forename: Neal S
authors.initials: NS
authors.lastname: Young
authors.forename: Edward L
authors.initials: EL
authors.lastname: Trimble
authors.forename: Richard F
authors.initials: RF
authors.lastname: Little
mesh_terms: D001741:Black or African American; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D005260:Female; D019650:Hematopoietic Stem Cell Mobilization; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D009503:Neutropenia / Q000139:chemically induced* / Q000175:diagnosis / Q000208:ethnology*; D009504:Neutrophils; D018579:Patient Selection
chemical_list: D000970:Antineoplastic Agents